The finding that PTGS2, ITGA4, and ANPEP may control acute kidney failure in the presence of RAAS inhibitors in DN is supported by the fact that all three are impacted by RAAS inhibitors and causal analysis using drug-target Mendelian randomization has demonstrated their link to acute kidney failure. This evidence concerns the gene PTGS2 and liver dysplastic nodule.